fbpx
Request Support
Request Info

Basal Cell Carcinoma

Xstrahl to Highlight Dual Modality Treatment Solution for Dermatologists at AOCD

Xstrahl to Highlight Dual Modality Treatment Solution for Dermatologists at AOCD

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the AOCD 2024 meeting, in Scottsdale, AZ. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring. Visit Xstrahl at AOCD 2024, booth # 22 at the Westin Kierland from April 11-14, 2024.

read more
Xstrahl to Showcase Radiant™ Aura at AAD 2024 in San Diego

Xstrahl to Showcase Radiant™ Aura at AAD 2024 in San Diego

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the Maui Derm Hawaii 2024 meeting, January 22-26, 2024. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.

read more
Xstrahl to feature Radiant™ Aura at Maui Derm Hawaii 2024

Xstrahl to feature Radiant™ Aura at Maui Derm Hawaii 2024

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the Maui Derm Hawaii 2024 meeting, January 22-26, 2024. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.

read more
Xstrahl to feature Radiant™ Aura at ASTRO 2023

Xstrahl to feature Radiant™ Aura at ASTRO 2023

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura, a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in San Diego, CA, October 1-3, 2023, booth #2216.

read more
The Dermatology Insider 2023

The Dermatology Insider 2023

The Dermatology Insider 2023 is Xstrahl’s magazine for dermatologists. This issue of the Dermatology Insider includes patient stories about having SRT treatment for their skin cancer. In addition, hear from a dermatologist as he describes his experience using radiation therapy to treat non-melanoma skin cancer (NMSC). See two case history reports of radiation therapy treatment for skin cancer using SRT and eBt, detailing the number of treatments, dose per treatment, reasons for radiation therapy, as well as before and after images of the results. Xstrahl introduces Radiant Aura, which recently received US Food & Drug Administration (FDA) 510(k) Clearance. We share more about using Radiant Aura and answer the most commonly asked questions in our FAQ section.

read more
Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance

Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance

Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance
Expands office-based treatment options for millions of non-melanoma skin cancer (NMSC) patients
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, announced its Radiant™ Aura treatment solution has received U.S. Food and Drug Administration (FDA) 510(k) clearance. With advanced features for expanded clinical use, simplified patient positioning, and additional patient comfort, Radiant Aura brings radiation therapy to NMSC patients in any dermatology office. 

read more
Two Case Histories: Office-Based Radiation Therapy for the Dermatology Clinic

Two Case Histories: Office-Based Radiation Therapy for the Dermatology Clinic

Dr. Sean E. Mazloom, MD, FAAD, from ReJUVA Dermatology, Vein & Skin Cancer Center, Venice, FL has been using the RADiant system to treat both squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) in his practice. Depending on a number of factors specific to each patient, he has treated these conditions with superficial radiation therapy (SRT) and electronic brachytherapy (eBT). Below are two case studies that describe the treatment process and results.

read more
Treating My Skin Cancer with Superficial Radiation Therapy was the Perfect Alternative to Surgery

Treating My Skin Cancer with Superficial Radiation Therapy was the Perfect Alternative to Surgery

Myrna has a history of multiple skin cancers that were treated with Mohs micrographic surgery. During the last year, Myrna was diagnosed twice with basal cell carcinomas (BCC). Her dermatologist, Dr. John Binhlam of Advanced Skin & Laser Center, in Brentwood, Tennessee recommended superficial radiation therapy (SRT) as an alternative to Mohs surgery based on several factors unique to her. Myrna had SRT treatment delivered with the RADiant system, right in Dr. Binhlam’s office.

read more

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Contact Us

Explore Related Categories

Mycosis Fungoides
Dupuytren's Contracture